It seems that the known therapy escape factor TGF-β1 [46] might render HPV− HNSCC cells responsive to growth factors such as EGF, FGF, NGF or BDNF, which support expansion of cell clones that survive therapeutic interventions. Here, NGF is linked to head and neck squamous cell carcinoma.